STANDARDIZATION OF HORMONE AND VETERINARY DRUG RESIDUE ANALYSIS IN ANIMAL PRODUCTS

---

Scientific Support Plan for a Sustainable Development Policy.
Standards for Foodproducts.

---

Monitoring programs: data obtained from the Annual Report of the Institute of Veterina Inspection (Belgium) for 1995.

Monitoring Programs 1995

1. Hormonal residues

1.1. Random research* at slaughterhouses:

* in the random research carcasses are chosen at random and not confiscated

Hormonal residues: products found

1.2. Directed control* at slaughterhouses:

* In the directed control suspected carcasses are analysed and confiscated awaiting the result of the analysis

Hormonal residues: products found

2. ß-Agonists or Corticosteroids residues

2.1. Random research at slaughterhouses:

ß-Agonists / Corticosteroids: products found

3. Anti-Hormonal residues

3.1. Random research at slaughterhouses:

3.2. Directed control at slaughterhouses:

4. Non-Hormonal residues

4.1. Random research at slaugtherhouses:

4.1.1. Antibiotics:

4.1.2. Sulfonamides:

9 samples were positive on a total of 288 analysed samples. These 9 samples were from pigs.

4.1.3. Chloramphenicol:

Despite the use of chloramphenicol is forbidden, 11 samples on a total of 279 were positive. 4 samples were from calves and 7 from pigs.

4.1.4. Oxfendazole-Fenbendazole:

On a total of 99 analysed samples, none were positive.

4.1.5. Ivermectine:

No samples were positive on a total of 100 analysed samples.

4.1.6. Tranquillizers:

17 samples were positive on a total of 288 analysed samples. These 17 samples were all from pigs.

4.1.7. ß-Agonists:

4.2. Directed control: Non-hormonal residues - antibiotics

5. Random research of poultry:

102 samples were analysed for the prescence of

a) antibiotics:

- sulfonamides

- tetracyclines

- enrofloxacine

b) flubendazole

c) -agonists

3 samples were positive for the presence of tetracyclines

6. Livestock breeding companies:

6.1. Directed control for substances with hormonal, -adrenergic or production stimulating action

* 196 samples were positive for forbidden compounds with oestrogenic, androgenic and gestagenic action, 12 samples were positive for compounds with -adrenergic and/or corticosteroid action

products found: